Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial

Ye Zhang,1,2 Shuqin Li,1,2 Cheng Wu,1,2 Liuyi Song,1,2 Li Hu,1,2 Jian Lu1,2 1Department of Anesthesiology, The Second Hospital of Jiaxing, The Second Affiliated Hospital of Jiaxing University, Jiaxing City, People’s Republic of China; 2Jiaxing Key Laboratory of Basic Research and Clinical Transforma...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Y, Li S, Wu C, Song L, Hu L, Lu J
Format: Article
Language:English
Published: Dove Medical Press 2025-08-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/effect-of-perioperative-subanesthetic-dose-of-esketamine-on-postoperat-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850047008437436416
author Zhang Y
Li S
Wu C
Song L
Hu L
Lu J
author_facet Zhang Y
Li S
Wu C
Song L
Hu L
Lu J
author_sort Zhang Y
collection DOAJ
description Ye Zhang,1,2 Shuqin Li,1,2 Cheng Wu,1,2 Liuyi Song,1,2 Li Hu,1,2 Jian Lu1,2 1Department of Anesthesiology, The Second Hospital of Jiaxing, The Second Affiliated Hospital of Jiaxing University, Jiaxing City, People’s Republic of China; 2Jiaxing Key Laboratory of Basic Research and Clinical Transformation of Perioperative Precision Anesthesia, Jiaxing City, People’s Republic of ChinaCorrespondence: Jian Lu, Email ljp200681@163.comBackground: To evaluate the effect of perioperative subanesthetic dose of esketamine on the postoperative recovery quality in patients undergoing laparoscopic gastrointestinal surgery.Methods: A total of 144 patients undergoing elective surgery for gastrointestinal tumors were selected and randomly assigned to either the esketamine group or the control group, with 72 patients in each group. Based on the standardized general anesthesia protocols, the esketamine group received an intravenous injection of esketamine at a dose of 0.2 mg/kg during the induction of anesthesia and an additional 0.2 mg/kg 30 minutes before the end of the surgery. Patient-controlled intravenous analgesia (PCIA) was administered for 48 hours, the esketamine group was treated with sufentanil (0.04 μg/kg/h) combined with esketamine (0.02 mg/kg/h) and sufentanil (0.04 μg/kg/h) was used as the control group. The scores of 40-items Quality of Recovery Scale (QoR-40) were recorded one day before surgery, one day after surgery, three days after surgery, and five days after surgery. Numerical Rating Scale (NRS) pain scores were recorded at postoperative intervals of 6 hours, 24 hours, 36 hours, and 48 hours. Levels of interleukin-6 (IL-6), tumor necrosis factor (TNF-α), and brain-derived neurotrophic factor (BDNF) in venous blood were analyzed prior to entering the operating room, upon arrival at the recovery room, and on the second postoperative day.Results: A total of 140 patients completed this study. Compared to the control group, the QoR-40 scores in the esketamine group were significantly higher at 1, 3, and 5 days post-surgery (Z = − 10.080, Z = − 8.178, Z = − 4.139, P < 0.05). In addition, the resting NRS scores were significantly lower at 6 hours, 24 hours, 36 hours, and 48 hours post-surgery in the esketamine group (Z=− 6.322, Z=− 5.736, Z=− 6.563, Z=− 5.920, P < 0.05).Conclusion: This study found that the perioperative use of subanesthetic esketamine improved early postoperative recovery quality and reduced postoperative pain levels in patients undergoing laparoscopic gastrointestinal surgery.Keywords: esketamine, recovery quality, laparoscopic gastrointestinal surgery, pain, anesthesia
format Article
id doaj-art-46328439feff4fab89c62aa5a14c9a39
institution DOAJ
issn 1177-8881
language English
publishDate 2025-08-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj-art-46328439feff4fab89c62aa5a14c9a392025-08-20T02:54:19ZengDove Medical PressDrug Design, Development and Therapy1177-88812025-08-01Volume 19Issue 166376646105376Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled TrialZhang YLi SWu C0Song LHu L1Lu J2anesthesiologyDepartment of AnesthesiologyAnesthesiology departmentYe Zhang,1,2 Shuqin Li,1,2 Cheng Wu,1,2 Liuyi Song,1,2 Li Hu,1,2 Jian Lu1,2 1Department of Anesthesiology, The Second Hospital of Jiaxing, The Second Affiliated Hospital of Jiaxing University, Jiaxing City, People’s Republic of China; 2Jiaxing Key Laboratory of Basic Research and Clinical Transformation of Perioperative Precision Anesthesia, Jiaxing City, People’s Republic of ChinaCorrespondence: Jian Lu, Email ljp200681@163.comBackground: To evaluate the effect of perioperative subanesthetic dose of esketamine on the postoperative recovery quality in patients undergoing laparoscopic gastrointestinal surgery.Methods: A total of 144 patients undergoing elective surgery for gastrointestinal tumors were selected and randomly assigned to either the esketamine group or the control group, with 72 patients in each group. Based on the standardized general anesthesia protocols, the esketamine group received an intravenous injection of esketamine at a dose of 0.2 mg/kg during the induction of anesthesia and an additional 0.2 mg/kg 30 minutes before the end of the surgery. Patient-controlled intravenous analgesia (PCIA) was administered for 48 hours, the esketamine group was treated with sufentanil (0.04 μg/kg/h) combined with esketamine (0.02 mg/kg/h) and sufentanil (0.04 μg/kg/h) was used as the control group. The scores of 40-items Quality of Recovery Scale (QoR-40) were recorded one day before surgery, one day after surgery, three days after surgery, and five days after surgery. Numerical Rating Scale (NRS) pain scores were recorded at postoperative intervals of 6 hours, 24 hours, 36 hours, and 48 hours. Levels of interleukin-6 (IL-6), tumor necrosis factor (TNF-α), and brain-derived neurotrophic factor (BDNF) in venous blood were analyzed prior to entering the operating room, upon arrival at the recovery room, and on the second postoperative day.Results: A total of 140 patients completed this study. Compared to the control group, the QoR-40 scores in the esketamine group were significantly higher at 1, 3, and 5 days post-surgery (Z = − 10.080, Z = − 8.178, Z = − 4.139, P < 0.05). In addition, the resting NRS scores were significantly lower at 6 hours, 24 hours, 36 hours, and 48 hours post-surgery in the esketamine group (Z=− 6.322, Z=− 5.736, Z=− 6.563, Z=− 5.920, P < 0.05).Conclusion: This study found that the perioperative use of subanesthetic esketamine improved early postoperative recovery quality and reduced postoperative pain levels in patients undergoing laparoscopic gastrointestinal surgery.Keywords: esketamine, recovery quality, laparoscopic gastrointestinal surgery, pain, anesthesiahttps://www.dovepress.com/effect-of-perioperative-subanesthetic-dose-of-esketamine-on-postoperat-peer-reviewed-fulltext-article-DDDTesketaminerecovery qualitylaparoscopic gastrointestinal surgerypainanesthesia.
spellingShingle Zhang Y
Li S
Wu C
Song L
Hu L
Lu J
Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial
Drug Design, Development and Therapy
esketamine
recovery quality
laparoscopic gastrointestinal surgery
pain
anesthesia.
title Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial
title_full Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial
title_fullStr Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial
title_full_unstemmed Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial
title_short Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial
title_sort effect of perioperative subanesthetic dose of esketamine on postoperative recovery quality in patients undergoing laparoscopic gastrointestinal surgery a randomised double blind controlled trial
topic esketamine
recovery quality
laparoscopic gastrointestinal surgery
pain
anesthesia.
url https://www.dovepress.com/effect-of-perioperative-subanesthetic-dose-of-esketamine-on-postoperat-peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT zhangy effectofperioperativesubanestheticdoseofesketamineonpostoperativerecoveryqualityinpatientsundergoinglaparoscopicgastrointestinalsurgeryarandomiseddoubleblindcontrolledtrial
AT lis effectofperioperativesubanestheticdoseofesketamineonpostoperativerecoveryqualityinpatientsundergoinglaparoscopicgastrointestinalsurgeryarandomiseddoubleblindcontrolledtrial
AT wuc effectofperioperativesubanestheticdoseofesketamineonpostoperativerecoveryqualityinpatientsundergoinglaparoscopicgastrointestinalsurgeryarandomiseddoubleblindcontrolledtrial
AT songl effectofperioperativesubanestheticdoseofesketamineonpostoperativerecoveryqualityinpatientsundergoinglaparoscopicgastrointestinalsurgeryarandomiseddoubleblindcontrolledtrial
AT hul effectofperioperativesubanestheticdoseofesketamineonpostoperativerecoveryqualityinpatientsundergoinglaparoscopicgastrointestinalsurgeryarandomiseddoubleblindcontrolledtrial
AT luj effectofperioperativesubanestheticdoseofesketamineonpostoperativerecoveryqualityinpatientsundergoinglaparoscopicgastrointestinalsurgeryarandomiseddoubleblindcontrolledtrial